β-Blocker Use and Cardiovascular Outcomes in Hemodialysis: A Systematic Review

RATIONALE & OBJECTIVE: There is conflicting evidence regarding the type of β-blockers to use in dialysis patients. This systematic review seeks to determine whether highly dialyzable β-blockers are associated with higher rates of cardiovascular events and mortality in hemodialysis patients than...

Descripción completa

Detalles Bibliográficos
Autores principales: Tella, Abhinav, Vang, William, Ikeri, Eustacia, Taylor, Olivia, Zhang, Alicia, Mazanec, Megan, Raju, Srihari, Ishani, Areef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079357/
https://www.ncbi.nlm.nih.gov/pubmed/35539430
http://dx.doi.org/10.1016/j.xkme.2022.100460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079357/
https://www.ncbi.nlm.nih.gov/pubmed/35539430
http://dx.doi.org/10.1016/j.xkme.2022.100460

Ejemplares similares